- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Indonesia Inc.
Total 1222 results
-
Astellas Pharma IncCompletedSecondary HyperparathyroidismJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C) | Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedConstipation-predominant Irritable Bowel Syndrome (IBS-C)Japan
-
Astellas Pharma IncCompletedRenal Anemia Associated With Chronic Renal Failure (CRF)Japan
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompletedHealthy SubjectsJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan
-
Astellas Pharma IncCompletedPsoriasisUnited States
-
Astellas Pharma IncCompletedArthritis, RheumatoidUnited States, Poland, Colombia, Belgium, Czechia, Bulgaria, Hungary, Mexico
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients With Impaired Hepatic FunctionJapan
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAlzheimer's DiseaseUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusType II Diabetes MellitusTaiwan, Korea, Republic of
-
Astellas Pharma IncCompletedType II Diabetes MellitusTaiwan, Korea, Republic of
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedCoronary Artery Disease (CAD)United States
-
Astellas Pharma IncCompletedKidney TransplantationBelgium, France, Italy, Sweden, Switzerland, Spain, Portugal, Russian Federation, Germany, Korea, Republic of, Czechia, Slovakia, Australia, Hungary, Netherlands, Romania, Estonia, Latvia, Mexico, Lithuania, Poland, Colombia, Finland, Norwa...
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedInsomnia | Sleep Initiation and Maintenance DisordersJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
Astellas Pharma IncCompletedNon-Hodgkin's LymphomaUnited States, France, Spain, United Kingdom
-
Astellas Pharma IncCompletedType 2 DiabetesJapan